Medical Journal: Drug Studies Hide Key Data
Posted on: Tuesday, 21 March 2006, 06:00 CST
By Sataline, S
"Several major pharmaceutical companies are withholding important details about clinical drug trials, despite urging from federal regulators and medical journal editors to be more forthcoming, according to a study published in this week's New England Journal of Medicine. The study says that companies including Merck & Co., Pfizer Inc., and GlaxoSmithKline PLC are obscuring basic information- including the names of some drugs under study-in reporting on trials of drugs to treat serious or life-threatening diseases. Some of the drugs involved are already on the market, and the companies are seeking approval for new uses of them. In an editorial, the journal calls for investigators and patients to avoid participating in drug trials where companies take a secretive approach."
Sataline S. Wall Street Journal. December 29, 2005
Noted by JFL, MD
Copyright American Academy of Pediatrics Mar 2006
Source: Pediatrics
Related Articles
- Study: Europe Drug Trials Need More Women
- FDA Considers Tighter Drug Trial Oversight
- WHO seeks greater openness in clinical drug trials
- Journal Calls for Change in Drug Trials
- Idea Offered for Drug Trial Illnesses
- Stanford Doctors Spotlight Fatal Flaw in Multiple Sclerosis Drug Trial
- Lilly Raises the Stakes With Heart Drug Trial
- Rockville-Based Human Genome Sciences Inc. Buoyed By Drug Trial
- More Transparency Offered in Drug Trials
 |
 |
User Comments (0)
RSS Feeds